4//SEC Filing
PHARMACYCLICS INC 4
Accession 0001209191-15-047701
CIK 0000949699operating
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:59 PM ET
Size
42.7 KB
Accession
0001209191-15-047701
Insider Transaction Report
Form 4
Mehta Minesh
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−238→ 0 totalExercise: $108.44Exp: 2024-01-02→ Common Stock (238 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−7,500→ 0 totalExercise: $14.26Exp: 2021-12-15→ Common Stock (7,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−3,750→ 0 totalExercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−157→ 0 totalExercise: $107.42Exp: 2024-04-01→ Common Stock (157 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−184→ 0 totalExercise: $139.89Exp: 2023-10-01→ Common Stock (184 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−3,750→ 0 totalExercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−407→ 0 totalExercise: $89.58Exp: 2024-07-01→ Common Stock (407 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−7,500→ 0 totalExercise: $49.00Exp: 2022-11-09→ Common Stock (7,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−146→ 0 totalExercise: $257.01Exp: 2025-04-07→ Common Stock (146 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−4,000→ 0 totalExercise: $2.30Exp: 2018-09-10→ Common Stock (4,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−208→ 0 totalExercise: $59.28Exp: 2022-07-02→ Common Stock (208 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−314→ 0 totalExercise: $115.80Exp: 2024-10-01→ Common Stock (314 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−222→ 0 totalExercise: $124.46Exp: 2025-01-02→ Common Stock (222 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−683→ 0 totalExercise: $28.47Exp: 2022-04-02→ Common Stock (683 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−267→ 0 totalExercise: $65.56Exp: 2022-10-01→ Common Stock (267 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−322→ 0 totalExercise: $61.44Exp: 2023-01-02→ Common Stock (322 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−325→ 0 totalExercise: $79.67Exp: 2023-04-01→ Common Stock (325 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−304→ 0 totalExercise: $85.39Exp: 2023-07-01→ Common Stock (304 underlying)
Footnotes (1)
- [F1]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000949699
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 6:59 PM ET
- Size
- 42.7 KB